bpc 157 peptide evidence safety BPC-157 Peptides in Orthopedics: What to Know The Peptide Clarity Handbook: A
Description
doi: 10.1155/2017/9012152 92 AustinMJKalampalikaFCawthornWPPatelB

Swine Administration: Inject intramuscularly or subcutaneously behind the ear, making sure to stay within the dose volume limits for each injection site

There is no validated dosing, safety, or monitoring protocol for BPC-157 in dogs, and it is a research-use-only compound not approved for animal treatment

The gradient starts from 97% A and hold for 0.5 min then decreased to 2% in 0.3 min, hold the 98% B for 0.4 min then returned to 97% A in 0.1 min and equilibrated for 0.7 min for waiting another injection

Thinning skin, vasculitis, purpuric dermatosis, platelet deficiency, liver disease, vitamin K deficiency, vitamin C deficiency, moving your body during the injection, or dehydration may also cause bruising

Singh, S., Tan, C., & Ahmad, A
